Most bought healthcare stocks in Q3 2025
Discover which Healthcare stocks institutional investors added to most aggressively over Q3 2025 versus the prior calendar quarter in our filings. Notable additions at the top of this list include BAXTER INTERNATIONAL INC (BAX), AVANTOR INC (AVTR), BOSTON SCIENTIFIC CORP (BSX), MSP RECOVERY INC -27 (LIFWW). These rankings aggregate SEC 13F filings from all institutional investors in our database.
Net share increases
Top symbols by net quarter-over-quarter share change (increases).
Most bought stocks
Net quarter-over-quarter share increases across all institutional filers.
| Symbol | Name | Net shares | Net value | New | Added | Trimmed | Sold out | Holding now |
|---|---|---|---|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | 27,064,487 | -$102.8M | 6 | 6 | 6 | 2 | 19 |
| AVTR | AVANTOR INC | 24,177,352 | $183.3M | 4 | 4 | 4 | 1 | 12 |
| BSX | BOSTON SCIENTIFIC CORP | 18,343,999 | $1.4B | 8 | 9 | 6 | 0 | 25 |
| LIFWW | MSP RECOVERY INC -27 | 13,162,948 | $24 | 1 | 0 | 0 | 0 | 1 |
| PFE | PFIZER INC | 11,297,102 | $94.8M | 15 | 12 | 13 | 3 | 42 |
| GEHC | GE HEALTHCARE TECHNOLOGY | 4,163,277 | $332.0M | 11 | 6 | 3 | 0 | 25 |
| PRME | PRIME MEDICINE INC | 4,090,779 | $30.4M | 2 | 2 | 0 | 0 | 5 |
| TRVI | TREVI THERAPEUTICS INC | 3,389,875 | $38.5M | 0 | 1 | 1 | 0 | 2 |
| SGMO | SANGAMO THERAPEUTICS INC | 3,343,029 | $3.2M | 0 | 1 | 0 | 0 | 2 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 3,130,172 | $3.9M | 0 | 1 | 0 | 0 | 2 |
| BMY | BRISTOL-MYERS SQUIBB CO | 3,112,441 | -$75.9M | 10 | 11 | 8 | 2 | 34 |
| EW | EDWARDS LIFESCIENCES CORP | 3,047,790 | $198.7M | 7 | 6 | 1 | 3 | 18 |
| BNTX | BIONTECH SE-ADR | 2,781,271 | $267.3M | 0 | 2 | 0 | 0 | 2 |
| ELV | ELEVANCE HEALTH INC | 2,733,319 | $74.0M | 9 | 9 | 7 | 4 | 31 |
| EXAS | EXACT SCIENCES CORP | 2,310,048 | $126.5M | 4 | 4 | 3 | 0 | 11 |
| BEAM | BEAM THERAPEUTICS INC | 2,203,849 | $117.7M | 2 | 2 | 0 | 0 | 4 |
| TECH | BIO-TECHNE CORP | 2,203,527 | $136.8M | 5 | 4 | 0 | 2 | 12 |
| ADAP | ADAPTIMMUNE THERAPEUTICS-ADR | 2,171,229 | $75.7K | 0 | 1 | 0 | 0 | 1 |
| ABSI | ABSCI CORP | 2,116,845 | $11.2M | 0 | 1 | 0 | 0 | 1 |
| DHR | DANAHER CORP | 2,082,689 | $367.1M | 13 | 6 | 12 | 0 | 35 |
| MRK | MERCK & CO. INC. | 2,076,084 | $112.1M | 12 | 14 | 9 | 3 | 42 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,033,887 | $40.5M | 2 | 2 | 0 | 0 | 6 |
| PEPG | PEPGEN INC | 2,024,400 | $14.7M | 0 | 2 | 0 | 0 | 2 |
| ORMP | ORAMED PHARMACEUTICALS INC | 1,977,757 | $5.3M | 1 | 1 | 0 | 0 | 2 |
| GILD | GILEAD SCIENCES INC | 1,933,236 | -$109.5M | 10 | 8 | 10 | 0 | 30 |
| SANA | SANA BIOTECHNOLOGY INC | 1,788,788 | $6.5M | 0 | 1 | 0 | 0 | 1 |
| VTRS | VIATRIS INC | 1,554,451 | $3.6M | 5 | 4 | 1 | 0 | 14 |
| WEAV | WEAVE COMMUNICATIONS INC | 1,553,881 | $8.7M | 1 | 2 | 0 | 0 | 3 |
| UHS | UNIVERSAL HEALTH SERVICES-B | 1,372,399 | $365.1M | 4 | 3 | 3 | 0 | 11 |
| ZBH | ZIMMER BIOMET HOLDINGS INC | 1,345,748 | $307.2M | 6 | 6 | 9 | 0 | 22 |
| ALLO | ALLOGENE THERAPEUTICS INC | 1,223,800 | $1.7M | 0 | 1 | 0 | 0 | 2 |
| PBH | PRESTIGE CONSUMER HEALTHCARE | 1,216,017 | $29.4M | 1 | 4 | 2 | 1 | 7 |
| CABA | CABALETTA BIO INC | 1,213,323 | $2.9M | 0 | 1 | 0 | 0 | 1 |
| CMPS | COMPASS PATHWAYS PLC | 1,210,497 | $12.4M | 1 | 2 | 0 | 0 | 3 |
| IGC | IGC PHARMA INC | 1,163,940 | $491.3K | 0 | 1 | 0 | 0 | 1 |
| REGN | REGENERON PHARMACEUTICALS | 1,098,419 | $759.5M | 7 | 6 | 6 | 1 | 19 |
| CAH | CARDINAL HEALTH INC | 1,074,104 | -$5.1M | 4 | 4 | 4 | 0 | 17 |
| FATE | FATE THERAPEUTICS INC | 1,048,152 | $1.4M | 1 | 1 | 0 | 0 | 4 |
| MDXG | MIMEDX GROUP INC | 1,022,586 | $8.7M | 1 | 2 | 1 | 0 | 4 |
| IBRX | IMMUNITYBIO INC | 1,021,759 | $2.5M | 1 | 2 | 0 | 0 | 4 |
| CPRX | CATALYST PHARMACEUTICALS INC | 947,048 | $6.8M | 2 | 3 | 1 | 1 | 6 |
| TDOC | TELADOC HEALTH INC | 933,020 | -$185.8K | 5 | 2 | 1 | 0 | 10 |
| BDX | BECTON DICKINSON AND CO | 910,215 | $302.2M | 5 | 3 | 7 | 4 | 17 |
| SOLV | SOLVENTUM CORP | 900,682 | $18.9M | 6 | 2 | 3 | 1 | 17 |
| MEIP | MEI PHARMA INC | 886,335 | $2.1M | 0 | 1 | 0 | 0 | 1 |
| PLRX | PLIANT THERAPEUTICS INC | 853,100 | $1.3M | 1 | 1 | 0 | 0 | 2 |
| JNJ | JOHNSON & JOHNSON | 849,584 | -$16.5M | 19 | 15 | 14 | 2 | 55 |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | 827,068 | $1.8M | 1 | 1 | 0 | 0 | 2 |
| CI | THE CIGNA GROUP | 799,019 | -$323.2M | 7 | 8 | 6 | 1 | 24 |
| GUTS | FRACTYL HEALTH INC | 776,700 | $1.2M | 1 | 0 | 0 | 0 | 1 |